Text Size

Prevalence of Ocular Surface Disease in Glaucoma Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT00382122
First received: September 27, 2006
Last updated: May 25, 2012
Last verified: September 2007
History of Changes
  Purpose

Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.


Condition Phase
Glaucoma
 Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Ocular Surface Disease in Glaucoma Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Alcon Research:

Enrollment: 101
Study Start Date: September 2006
Study Completion Date: February 2007
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients 18 years or older with open-angle glaucoma or ocular hypertension were consecutively recruited for the study.

Criteria

Inclusion Criteria:

  • Diagnosis of glaucoma;
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Inability to understand trial procedures;
  • Inability to understand Informed Consent;
  • Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
  • Punctal plugs;
  • Previous glaucoma, corneal, or conjunctival surgery;
  • Other protocol-defined exclusion criteria may apply.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00382122

Locations
United States, California
La Jolla
La Jolla, California, United States, 92093
Sponsors and Collaborators
Alcon Research
Investigators
Study Director: Felipe Medeiros, MD, PhD University of California, San Diego
  More Information

Publications:

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00382122     History of Changes
Other Study ID Numbers: CMS-06-06
Study First Received: September 27, 2006
Last Updated: May 25, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Alcon Research:
Glaucoma
Ocular hypertension
Dry eye
Ocular surface disease

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 21, 2013